This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents. Top assignees: Regeneron Pharmaceuticals, Inc., Regeneran Pharmaceuticals, Inc.. Active years: 2021-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- White Plains, NY (US) (2021)
- Waldwick, NJ (US) (2022)
Company Filing History:
2 out of 1,482 
1 out of 49 Years Active: 2021-2022
Title: Inventor Jaimie Mastrogiacomo: Innovating in Aflibercept Production
Introduction
Jaimie Mastrogiacomo is a prominent inventor based in White Plains, NY, known for his contributions to the field of biopharmaceuticals. With three patents to his name, Mastrogiacomo has made significant strides in developing methods to improve the production of aflibercept, a critical drug for treating various eye diseases.
Latest Patents
Mastrogiacomo's latest patents focus on "Methods for producing aflibercept in chemically defined media having reduced aflibercept variants." This innovative work pertains to compositions comprising anti-VEGF proteins, alongside the methods for producing such compositions. His inventions aim to enhance the efficacy and stability of aflibercept, ultimately benefiting patients requiring treatment for age-related macular degeneration and other related conditions.
Career Highlights
Throughout his career, Jaimie Mastrogiacomo has held significant positions at well-respected organizations, including Regeneron Pharmaceuticals, Inc. and Regeneron Pharmaceuticals, Inc. His experience in these companies has greatly contributed to his knowledge and expertise in the pharmaceutical biotech sector, particularly in the development of therapeutic proteins.
Collaborations
Mastrogiacomo has collaborated with talented professionals in the field, including Shawn M. Lawrence and Amy S. Johnson. These partnerships have fostered an environment of innovation, enabling him to advance the methods and compositions associated with his patents.
Conclusion
In conclusion, Jaimie Mastrogiacomo remains a key figure in the field of biopharmaceuticals, driving critical innovations in aflibercept production. With multiple patents and invaluable collaborations under his belt, he continues to make impactful contributions that enhance treatment methodologies for eye diseases and beyond.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile